PROVIDER PROFILE · NPI 1871777573

Teja BediMD

PRESCRIBING · PART D · 2024
Total Rx claims
404
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
21
Brand share
43.1%
Top prescribed drugs
Anastrozole69 claims
Ibrutinib27 claims
Omeprazole25 claims
Bosutinib23 claims
Hydroxyurea22 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.